A cost-effectiveness model for smoking cessation therapy using varenicline

被引：0
|
作者：
Viswanathan, S. [1 ]
Neville, W. [1 ]
Patel, E. [1 ]
Raparla, S. [1 ]
McGhan, W. F. [1 ]
机构：
[1] Univ Sci Philadelphia, Philadelphia, PA USA
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)70854-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A270 / A271
页数：2
相关论文
共 50 条
  • [1] THE COST-EFFECTIVENESS OF VARENICLINE IN SMOKING CESSATION IN DENMARK
    Poulsen, P. B.
    Dollerup, J.
    Keiding, H.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A450 - A450
  • [2] THE COST-EFFECTIVENESS ANALYSIS OF VARENICLINE FOR SMOKING CESSATION IN POLAND
    Walczak, J.
    Nogas, G.
    Dybek-Karpiuk, A.
    Augustynska, J.
    Stelmachowski, J.
    Garbacka, M.
    Obrzut, G.
    Pawlik, D.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A303 - A303
  • [3] COST-EFFECTIVENESS OF VARENICLINE VS EXISTING SMOKING CESSATION STRATEGIES IN DOMINICAN REPUBLIC USING THE BENESCO MODEL
    Lutz, M.
    Morales, G.
    Cuesta, G.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A566 - A566
  • [4] A cost-effectiveness analysis of varenicline for smoking cessation using data from the EAGLES trial
    Baker, Christine L.
    Pietri, Guilhem
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2018, 10 : 67 - 74
  • [5] Cost-effectiveness analysis of Champix® (varenicline) in smoking cessation treatment in Spain
    F Bobadilla, J.
    Brosa, M.
    Wilson, K.
    Sánchez Maestre, C.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A471 - A472
  • [6] Using cost-effectiveness analysis to support policy change: varenicline and nicotine replacement therapy for smoking cessation in Jordan
    Madae'en, Saba
    Obeidat, Nour
    Adeinat, Mohammad
    [J]. JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2020, 13 (01)
  • [7] Using cost-effectiveness analysis to support policy change: varenicline and nicotine replacement therapy for smoking cessation in Jordan
    Saba Madae’en
    Nour Obeidat
    Mohammad Adeinat
    [J]. Journal of Pharmaceutical Policy and Practice, 13
  • [8] COST-EFFECTIVENESS OF VARENICLINE VERSUS EXISTING SMOKING CESSATION STRATEGIES IN CENTRAL AMERICA AND THE CARIBBEAN USING THE BENESCO MODEL
    Lutz, M.
    Lovato, P.
    Cuesta, G.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A139 - A139
  • [9] Systematic review of the cost-effectiveness of varenicline vs. bupropion for smoking cessation
    Mahmoudi, M.
    Coleman, C. I.
    Sobieraj, D. M.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (02) : 171 - 182
  • [10] COST-EFFECTIVENESS OF VARENICLINE COMPARED WITH BUPROPION AND NRT (NICORETTE) FOR SMOKING CESSATION IN AUSTRIA
    Walter, E.
    Mercsanits, D.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A563 - A563
12345